“…Gelatin represents an optimal choice to prepare ECM biomimetic hydrogels. In fact, being a collagen derivative, gelatin possesses unique advantages, compared to other synthetic and natural-derived polymers, including intrinsic presence of cell-adhesive motifs and MMP-sensitive sequences that guarantee cell adhesion and matrix remodeling, fundamental for cell-biomaterial interactions and potential tissue formation/regeneration. , Collagen source (e.g., porcine, bovine, fish) and its processing to extract gelatin (e.g., acidic or alkaline for type A and type B gelatin, respectively) can heavily influence the properties of the obtained gelatin hydrogels. , Thus, we selected type B gelatin as, compared to other gelatin types, it induces minor in vivo inflammatory response, and it exhibits lower immunogenicity and higher cytocompatibility. , Moreover, we prepared hydrogels using low-endotoxin gelatin, as controlled endotoxin levels must be guaranteed for potential translation from in vitro studies to in vivo applications, given regulatory constraints and endotoxin-related potential inflammatory effects …”